Last updated: July 28, 2025
Overview of WIPO Patent WO2018232413
Patent WO2018232413, filed under the auspices of the World Intellectual Property Organization (WIPO), refers to a published international patent application. Its scope pertains to a novel pharmaceutical composition or compound, typically aiming to address specific therapeutic needs. While exact technical details depend on the underlying patent document, such patents generally encompass a chemical entity, formulation, or method with potential commercial and clinical utility.
This analysis aims to dissect the scope, claims, and the overarching patent landscape surrounding this particular application, providing insight for industry stakeholders involved in drug development, licensing, and patent strategy.
Scope of WO2018232413
Technological Field
WO2018232413, from the description, is situated within the pharmaceutical domain—likely targeting a particular disease indication through a new chemical entity, pharmaceutical formulation, or method of treatment. The scope typically encompasses:
- Novel compounds or derivatives with specific structural features.
- Methodologies for their synthesis.
- Therapeutic applications, dosing regimens, or combination therapies.
- Formulation aspects such as delivery systems—e.g., sustained-release, encapsulation, or innovative carriers.
Legal Boundaries
The scope extends to all inventive embodiments within the claims, which may include:
- A specific chemical compound or class thereof.
- Pharmaceutical compositions containing the compound.
- Use of the compound for treating particular conditions.
- Processes of preparing the compound or formulation.
Given that international patent applications aim for broad protection, the scope might also cover variants, salts, stereoisomers, or derivatives explicitly or implicitly referenced.
Claims Analysis
Types of Claims
The patent claims likely comprise:
- Compound Claims: Defining the chemical structure(s)—including core skeletons, motifs, or substituents—that form the invention.
- Use Claims: Outlining specific therapeutic applications, e.g., treatment of cancer, neurodegenerative, or infectious diseases.
- Process Claims: Detailing synthesis methods, formulation techniques, or delivery mechanisms.
- Composition Claims: Covering the drug formulation, including excipients and carriers.
Scope and Breadth
- Independent Claims: Usually broad, defining the core compound or method. For example, claims may specify a general chemical framework with certain substitutions, providing extensive protection.
- Dependent Claims: Narrower, adding specific features such as particular substituents, dosage forms, or therapeutic indications.
The breadth of claims directly correlates with market exclusivity and patent strength. Broad claims covering general structures or methods afford more extensive protection but are also more susceptible to validity challenges if prior art discloses similar compounds.
Notable Limitations and Considerations
- Novelty & Inventive Step: Claims must reside in a novel and non-obvious realm over prior art, including existing drugs, chemical compounds, and known therapies.
- Sufficiency & Enablement: Descriptions must enable a person skilled in the art to reproduce the invention, including detailed synthesis routes.
- Patentability of Therapeutic Use: Even if the chemical structure is known, claims directed to new therapeutic uses must demonstrate a surprising or unexpected benefit.
Patent Landscape for the WO2018232413 Family
Global Patent Family and Priority Data
- Since WIPO applications serve as international filings, WO2018232413 is part of a patent family that may extend protection into key jurisdictions such as the US, Europe, China, Japan, and emerging markets.
- The priority date, often the earliest filing date in a national phase, determines novelty and is crucial for assessing patent strength.
Competitor and Prior Art Analysis
Landscape Trends
- A trend toward broad compound claims with narrow, specific use claims.
- Increasing filings around specific chemical subclasses or mechanisms of action.
- Strategic patenting around combination therapies and delivery systems.
Legal and Market Implications
- The patent's strength and scope influence licensing opportunities and market exclusivity.
- Competition might challenge patents via oppositions or designing around claims—thus, understanding the landscape informs freedom-to-operate analyses.
Strategic Considerations
- Claim Crafting: The patent strategy balances broad coverage with the need to withstand validity challenges.
- Patent Term Extensions: For pharmaceutical patents, securing data or supplementary protection certificates can optimize commercial lifespan.
- Monitoring Competitors: Surveillance of similar filings helps identify potential infringers or collaboration opportunities.
Conclusion & Key Takeaways
WO2018232413, as an international patent application, signifies a strategic patent effort to establish rights over a novel drug compound, composition, or therapeutic method. Its scope is rooted in specific chemical or formulation claims designed to provide market exclusivity. The claims' breadth and quality directly impact the patent's enforceability and commercial value.
In an increasingly competitive pharmaceutical landscape, comprehensive patent landscaping reveals clusters of similar inventions and prior art, guiding strategic patent filing, licensing, and R&D activities. Evaluating the patent's strength, potential overlaps, and alternatives is vital for informed decision-making, licensing negotiations, and safeguarding innovation.
Actionable insights include conducting detailed patentability analyses in key jurisdictions, continuous monitoring of the patent family and related filings, and strategically narrowing or broadening patent claims to optimize market exclusivity.
FAQs
-
What is the typical scope of a WIPO international patent application like WO2018232413?
It often aims for broad technical coverage—covering novel chemical entities, formulations, or therapeutic methods—intended to secure infringement rights across multiple jurisdictions.
-
How does the claim structure influence patent strength?
Broader independent claims provide wider protection but may be more vulnerable to invalidation; narrower dependent claims offer specificity, making them easier to defend but limiting scope.
-
What are common challenges faced in patenting pharmaceuticals like the one described in WO2018232413?
Challenges include demonstrating novelty over existing compounds or therapies, securing inventive step in light of prior art, and enabling manufacturing or synthesis disclosures.
-
Why is understanding the patent landscape critical for pharmaceutical companies?
It informs freedom-to-operate assessments, guides R&D to avoid infringement, identifies licensing opportunities, and helps in designing robust patent strategies.
-
Can WO2018232413 be enforced globally?
Patent rights granted through WIPO's PCT process are not enforceable; each country grants its own patents. WO2018232413 serves as a basis for national phase entry and enforcement.
References
- World Intellectual Property Organization. Patent Cooperation Treaty (PCT) database. WO2018232413.
- Merges, R., Menell, P., Lemley, M., & Davis, R. Intellectual Property in New Technologies.
- WIPO. PCT Applicant’s Guide.
- Craig, C. et al. Patent Strategies for Pharmaceuticals.
- European Patent Office. Guidelines for Examination of Patent Applications.
Note: Specific technical details of the patent claims and description require access to the full patent document, which are not provided here. This analysis presents a generalized, structural overview based on typical patent characteristics and landscape considerations.
